Nu Skin Enterprises Debt to Equity Ratio 2012-2026 | NUS
Current and historical debt to equity ratio values for Nu Skin Enterprises (NUS) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Nu Skin Enterprises debt/equity for the three months ending March 31, 2026 was 0.25.
| Nu Skin Enterprises Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2026-03-31 | $0.58B | $0.79B | 0.73 |
| 2025-12-31 | $0.60B | $0.81B | 0.75 |
| 2025-09-30 | $0.63B | $0.80B | 0.78 |
| 2025-06-30 | $0.66B | $0.79B | 0.83 |
| 2025-03-31 | $0.64B | $0.75B | 0.85 |
| 2024-12-31 | $0.82B | $0.65B | 1.26 |
| 2024-09-30 | $0.88B | $0.71B | 1.24 |
| 2024-06-30 | $0.90B | $0.69B | 1.31 |
| 2024-03-31 | $0.93B | $0.81B | 1.15 |
| 2023-12-31 | $0.99B | $0.82B | 1.20 |
| 2023-09-30 | $0.97B | $0.82B | 1.18 |
| 2023-06-30 | $1.00B | $0.90B | 1.12 |
| 2023-03-31 | $0.93B | $0.89B | 1.04 |
| 2022-12-31 | $0.92B | $0.90B | 1.03 |
| 2022-09-30 | $0.92B | $0.84B | 1.09 |
| 2022-06-30 | $0.96B | $0.94B | 1.02 |
| 2022-03-31 | $0.96B | $0.93B | 1.03 |
| 2021-12-31 | $0.99B | $0.91B | 1.09 |
| 2021-09-30 | $1.04B | $0.94B | 1.11 |
| 2021-06-30 | $1.13B | $0.92B | 1.23 |
| 2021-03-31 | $1.08B | $0.87B | 1.24 |
| 2020-12-31 | $1.06B | $0.89B | 1.19 |
| 2020-09-30 | $0.99B | $0.83B | 1.20 |
| 2020-06-30 | $1.00B | $0.79B | 1.27 |
| 2020-03-31 | $0.95B | $0.80B | 1.18 |
| 2019-12-31 | $0.89B | $0.88B | 1.02 |
| 2019-09-30 | $0.89B | $0.85B | 1.05 |
| 2019-06-30 | $0.96B | $0.84B | 1.15 |
| 2019-03-31 | $0.94B | $0.81B | 1.16 |
| 2018-12-31 | $0.91B | $0.78B | 1.17 |
| 2018-09-30 | $0.91B | $0.83B | 1.10 |
| 2018-06-30 | $0.94B | $0.80B | 1.17 |
| 2018-03-31 | $0.98B | $0.80B | 1.22 |
| 2017-12-31 | $0.89B | $0.71B | 1.26 |
| 2017-09-30 | $0.83B | $0.72B | 1.16 |
| 2017-06-30 | $0.81B | $0.70B | 1.15 |
| 2017-03-31 | $0.81B | $0.69B | 1.17 |
| 2016-12-31 | $0.81B | $0.66B | 1.22 |
| 2016-09-30 | $0.90B | $0.85B | 1.05 |
| 2016-06-30 | $0.95B | $0.83B | 1.15 |
| 2016-03-31 | $0.71B | $0.80B | 0.89 |
| 2015-12-31 | $0.68B | $0.83B | 0.82 |
| 2015-09-30 | $0.69B | $0.86B | 0.81 |
| 2015-06-30 | $0.70B | $0.90B | 0.77 |
| 2015-03-31 | $0.69B | $0.92B | 0.75 |
| 2014-12-31 | $0.67B | $0.94B | 0.71 |
| 2014-09-30 | $0.63B | $0.94B | 0.68 |
| 2014-06-30 | $0.71B | $0.89B | 0.80 |
| 2014-03-31 | $0.77B | $0.88B | 0.88 |
| 2013-12-31 | $0.96B | $0.86B | 1.12 |
| 2013-09-30 | $0.95B | $0.74B | 1.27 |
| 2013-06-30 | $0.70B | $0.69B | 1.01 |
| 2013-03-31 | $0.59B | $0.62B | 0.96 |
| 2012-12-31 | $0.53B | $0.59B | 0.90 |
| 2012-09-30 | $0.57B | $0.55B | 1.03 |
| 2012-06-30 | $0.57B | $0.57B | 1.00 |
| 2012-03-31 | $0.41B | $0.62B | 0.66 |
| 2011-12-31 | $0.42B | $0.57B | 0.73 |
| 2011-09-30 | $0.36B | $0.54B | 0.66 |
| 2011-06-30 | $0.38B | $0.51B | 0.75 |
| 2011-03-31 | $0.39B | $0.47B | 0.83 |
| 2010-12-31 | $0.42B | $0.47B | 0.89 |
| 2010-09-30 | $0.39B | $0.43B | 0.90 |
| 2010-06-30 | $0.37B | $0.40B | 0.92 |
| 2010-03-31 | $0.37B | $0.40B | 0.94 |
| 2009-12-31 | $0.37B | $0.38B | 0.99 |
| 2009-09-30 | $0.39B | $0.35B | 1.12 |
| 2009-06-30 | $0.37B | $0.34B | 1.12 |
| 2009-03-31 | $0.38B | $0.32B | 1.18 |
| 2008-12-31 | $0.39B | $0.32B | 1.25 |
| 2008-09-30 | $0.37B | $0.31B | 1.22 |
| 2008-06-30 | $0.39B | $0.30B | 1.32 |
| 2008-03-31 | $0.41B | $0.28B | 1.45 |
| 2007-12-31 | $0.41B | $0.28B | 1.48 |
| 2007-09-30 | $0.42B | $0.30B | 1.42 |
| 2007-06-30 | $0.40B | $0.29B | 1.37 |
| 2007-03-31 | $0.41B | $0.28B | 1.48 |
| 2006-12-31 | $0.35B | $0.32B | 1.08 |
| 2006-09-30 | $0.32B | $0.33B | 0.96 |
| 2006-06-30 | $0.31B | $0.35B | 0.88 |
| 2006-03-31 | $0.32B | $0.34B | 0.93 |
| 2005-12-31 | $0.32B | $0.36B | 0.91 |
| 2005-09-30 | $0.32B | $0.35B | 0.91 |
| 2005-06-30 | $0.33B | $0.34B | 0.99 |
| 2005-03-31 | $0.34B | $0.32B | 1.09 |
| 2004-12-31 | $0.31B | $0.30B | 1.06 |
| 2004-09-30 | $0.30B | $0.28B | 1.05 |
| 2004-06-30 | $0.29B | $0.32B | 0.91 |
| 2004-03-31 | $0.30B | $0.31B | 0.98 |
| 2003-12-31 | $0.30B | $0.29B | 1.04 |
| 2003-09-30 | $0.22B | $0.41B | 0.54 |
| 2003-06-30 | $0.20B | $0.40B | 0.50 |
| 2003-03-31 | $0.21B | $0.39B | 0.55 |
| 2002-12-31 | $0.23B | $0.39B | 0.58 |
| 2002-09-30 | $0.21B | $0.38B | 0.56 |
| 2002-06-30 | $0.22B | $0.37B | 0.60 |
| 2002-03-31 | $0.20B | $0.38B | 0.52 |
| 2001-12-31 | $0.20B | $0.38B | 0.53 |
| 2001-09-30 | $0.21B | $0.36B | 0.59 |
| 2001-06-30 | $0.21B | $0.37B | 0.58 |
| 2001-03-31 | $0.20B | $0.37B | 0.55 |
| 2000-12-31 | $0.22B | $0.37B | 0.61 |
| 2000-09-30 | $0.24B | $0.35B | 0.68 |
| 2000-06-30 | $0.25B | $0.34B | 0.74 |
| 2000-03-31 | $0.26B | $0.32B | 0.79 |
| 1999-12-31 | $0.33B | $0.31B | 1.08 |
| 1999-09-30 | $0.31B | $0.31B | 0.99 |
| 1999-06-30 | $0.31B | $0.27B | 1.15 |
| 1999-03-31 | $0.31B | $0.27B | 1.15 |
| 1998-12-31 | $0.35B | $0.26B | 1.38 |
| 1998-09-30 | $0.29B | $0.19B | 1.53 |
| 1998-06-30 | $0.31B | $0.16B | 1.96 |
| 1998-03-31 | $0.34B | $0.14B | 2.38 |
| 1997-12-31 | $0.18B | $0.18B | 0.99 |
| 1997-09-30 | $0.14B | $0.19B | 0.75 |
| 1997-06-30 | $0.15B | $0.16B | 0.90 |
| 1997-03-31 | $0.21B | $0.13B | 1.63 |
| 1996-12-31 | $0.22B | $0.11B | 2.08 |
| 1996-06-30 | $0.00B | 0.00 | |
| 1995-12-31 | $0.06B | $0.06B | 0.91 |
| 1994-12-31 | $0.00B | 0.00 | |
| 1993-12-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Consumer Staples | Cosmetics and Toiletries | $0.362B | $1.485B |
| Nu Skin develops and distributes a wide range of premium cosmetics, beauty, personal care and wellness products. While the company specializes in beauty and personal care, it also provides a wide range of nutritional products. Nu Skin's products are available in markets worldwide. From a product perspective, the company operates through two brand categories namely, Nu Skin and Pharmanex. The company offers premium quality personal care products under the Nu Skin brand banner, while nutritional supplements are marketed under Pharmanex. The company has evolved strongly in the skin care treatments arena, more particularly in anti-aging products. Some of the renowned brands of the company in skin care includes ageLOC and Epoch. The company also provides a wide range of hair care and other personal care items. In addition to these, the company offers a diverse range of nutritional and weight management products such as ageLOC Youth nutritional supplement and LifePak nutritional supplements. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estee Lauder (EL) | United States | $26.287B | 37.27 |
| DSM Firmenich AG - (DSFIY) | Switzerland | $18.794B | 0.00 |
| Shiseido (SSDOY) | Japan | $8.470B | 235.56 |
| E.l.f Beauty (ELF) | United States | $3.846B | 26.05 |
| POLA ORBIS (PORBF) | Japan | $1.925B | 22.31 |
| Coty (COTY) | United States | $1.910B | 9.86 |
| Helen Of Troy (HELE) | Bermuda | $0.386B | 3.96 |
| European Wax Center (EWCZ) | United States | $0.317B | 8.20 |
| Pitanium (PTNM) | Hong Kong, SAR China | $0.208B | 0.00 |
| Empro Group (EMPG) | $0.141B | 0.00 | |
| Waldencast (WALD) | United Kingdom | $0.133B | 0.00 |
| Solesence (SLSN) | United States | $0.078B | 55.50 |
| Natura &Co Holding S.A ADR (NTCOY) | Brazil | $0.000B | 0.00 |